Vimarsana
Biggest News Aggregation in the World

Page 17 - Eceptor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eceptor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eceptor Today - Breaking & Trending Today

Immune checkpoint inhibitor target found to promote skin cancer growth - Vimarsana News

Immune checkpoint inhibitor target found to promote skin cancer growth

Programmed cell death 1 (PD-1) is an important target for immune checkpoint inhibitor therapies that block its signaling and boost T-cell activity. PD-1 inhibitors have been approved for treating various types of cancer.

Important discovery could lead to novel treatment for obesity - Vimarsana News

Important discovery could lead to novel treatment for obesity

A team comprised primarily of Texas A&M AgriLife Research scientists has made an important discovery that could lead to a novel treatment for obesity and obesity-associated diseases or conditions.

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery - Vimarsana News

New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery

A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains.

Evaluating the effectiveness and safety of single-port robot-assisted technique in nipple-sparing mastectomy procedures - Vimarsana News

Evaluating the effectiveness and safety of single-port robot-assisted technique in nipple-sparing mastectomy procedures

Researchers evaluated the safety and feasibility of a single-port (SP) robotic-assisted approach for performing nipple-sparing mastectomies (NSM).

Mathetatical modeling demonstrates efficacy of combinational drug therapy for breast cancer treatment - Vimarsana News

Mathetatical modeling demonstrates efficacy of combinational drug therapy for breast cancer treatment

Researchers use a mathematical model to assess the efficacy of a new combinational therapy of AZD9496 and palbociclib for breast cancer treatment.